Ritodrine hydrochloride

Ritodrine Hydrochloride is the hydrochloride salt form of ritodrine, a phenethylamine derivative with tocolytic activity. Ritodrine hydrochloride binds to and activates beta-2 adrenergic receptors of myocytes in the uterine myometrium, which results in decreased intensity and frequency of uterine contraction. Specifically, ritodrine hydrochloride probably activates adenyl cyclase, thereby increasing production of cyclic adenosine monophosphate (cAMP), which in turn enhancing the efflux of calcium from vascular smooth muscle cells. A lack of intracellular calcium prevents uterine myometrial contraction. Additionally, this agent may directly inactivate myosin light chain kinase, a critical enzyme necessary for the initiation of muscle contractions. It is grouped under the following drug class(es): Beta-2 agonists. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Luteonin, Pre-Par, Yutopar and NSC-291565. Its PubChem CID is 3040551.

CAS No 23239-51-2
Molecular Formula C17H22ClNO3
Molecular Weight 323.8 g/mol
Synonyms 4-[2-[[(1S,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol;hydrochloride

Frequently Asked Questions